<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699398</url>
  </required_header>
  <id_info>
    <org_study_id>AAL-2008-1-1191</org_study_id>
    <nct_id>NCT02699398</nct_id>
  </id_info>
  <brief_title>Domiciliary VR Rehabilitation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Pompeu Fabra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Vall d'Hebron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitat Pompeu Fabra</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether domiciliary VR-based telerehabilitation is
      superior than domiciliary occupational therapy for inducing functional gains, enhancing
      corticospinal excitability, and cortical reorganization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in motor function for activities of daily living as measured by Chedoke Arm Hand Inventory clinical</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in depression as measured by the Hamilton scale</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in motor function as measured by the Medical Research Council scale</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in spasticity for the upper arms as measured by the Ashworth scale</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive function as measured by the Mini-mental State Evaluation test</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Grip Force as measured by a grip dynamometer</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in shoulder pain as measured by the Visual Analog Assessment scale</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in motor function as measured by the upper extremity Fugl-Meyer Assessment</measure>
    <time_frame>At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Hemiparesis</condition>
  <condition>Functional Independence</condition>
  <condition>Movement Disorder</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>VR-based therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 weeks of home-based treatment for motor training using a virtual reality rehabilitation setup.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 weeks of home-based occupational therapy for motor training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Domiciliary VR-based motor rehabilitation</intervention_name>
    <description>3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.</description>
    <arm_group_label>VR-based therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Domiciliary occupational therapy for motor rehabilitation</intervention_name>
    <description>3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Hemorrhagic or ischemic stroke

          -  Subject had the stroke more than 12 months ago.

          -  Subject presents mild-to-moderate upper-limbs hemiparesis (Proximal Medial Research
             Council Scale&gt;2) secondary to a first-ever stroke.

          -  Age between 45 and 85 years old.

          -  Subject has previous experience using the RGS system in the clinic.

        Exclusion Criteria:

          -  Subject presents a major cognitive impairment (Mini-Mental State Evaluation&gt; 22).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Verschure, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Synthetic Perceptive, Emotive and Cognitive Systems group, Department of Information and Communication Technologies at the Universitat Pompeu Fabra (UPF).</affiliation>
  </overall_official>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>February 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>February 29, 2016</last_update_submitted>
  <last_update_submitted_qc>February 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Pompeu Fabra</investigator_affiliation>
    <investigator_full_name>Paul Verschure</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Movement Disorders</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

